OTLK Earnings Results and History
Outlook Therapeutics, Inc.'s earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
- Revenue–
- Net income−$13.3M
- EPS (GAAP)−$0.19
Filed Aug 18, 2026. The next earnings release shows here within a minute of filing.
EPS by quarter
GAAP diluted, 9 quartersRevenue and operating margin
from 10-Q and 10-KQuarter by quarter
from 10-Q and 10-K filings| Quarter ended | Revenue | Growth | Gross margin | Op margin | Net income | EPS |
|---|---|---|---|---|---|---|
| Sep 2025 | – | – | – | – | −$13.3M | −$0.19 |
| Jun 2025 | $1.5M | – | 70.8% | −1046.2% | −$20.2M | −$0.55 |
| Sep 2019 | $5.9M | +658.3% | – | – | – | – |
| Jun 2019 | $584K | −24.4% | – | – | – | – |
EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.
Reports and price reactions
last 1 reportsYear by year
fiscal years, from 10-K filings| Year ended | Revenue | Growth | Op margin | Net income | EPS |
|---|---|---|---|---|---|
| Sep 30, 2025 | $1.4M | −82.6% | −4744.3% | −$62.4M | −$1.79 |
| Sep 30, 2019 | $8.1M | +163.8% | −445.6% | −$34.5M | −$1.98 |
| Sep 30, 2018 | $3.1M | – | −960.1% | −$30.1M | −$1.22 |
Filings and dates
SEC EDGAR- Dec 18, 2026Next earnings reportexpected
- Aug 18, 2026Quarterly report10-Q All filings
Also see OTLK institutional ownership and the earnings calendar.
OTLK earnings FAQ
When is OTLK's next earnings date?
Outlook Therapeutics, Inc. is expected to report on Dec 18, 2026. Dates can move until the company confirms them.
Is OTLK's revenue growing?
In the quarter ended Sep 30, 2025 revenue was . The table on this page shows every quarter from the company's 10-Q and 10-K filings.
Where do these numbers come from?
Results, guidance and financials come from Outlook Therapeutics, Inc.'s own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.